MADRIGAL PHARMACEU

The current price of YDO1 is 227.047 CHF — it has increased by 2.24% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on BX exchange MADRIGAL PHARMACEU stocks are traded under the ticker YDO1.

MADRIGAL PHARMACEU is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.

YDO1 stock is 2.19% volatile and has beta coefficient of 1.88. Check out the list of the most volatile stocks — is MADRIGAL PHARMACEU there?

YDO1 earnings for the last quarter are −4.89 CHF per share, whereas the estimation was −4.48 CHF resulting in a −9.08% surprise. The estimated earnings for the next quarter are −4.41 CHF per share. See more details about MADRIGAL PHARMACEU earnings.

Yes, you can track MADRIGAL PHARMACEU financials in yearly and quarterly reports right on TradingView.

Today MADRIGAL PHARMACEU has the market capitalization of ‪3.71 B‬, it has increased by 1.44% over the last week.

No, YDO1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, YDO1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MADRIGAL PHARMACEU stock right from TradingView charts — choose your broker and connect to your account.

YDO1 reached its all-time high on Mar 21, 2024 with the price of 231.507 CHF, and its all-time low was 157.036 CHF and was reached on Sep 13, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 28, 2024, the company has 376.00 employees. See our rating of the largest employees — is MADRIGAL PHARMACEU on this list?

We've gathered analysts' opinions on MADRIGAL PHARMACEU future price: according to them, YDO1 price has a max estimate of 515.83 CHF and a min estimate of 136.95 CHF. Read a more detailed MADRIGAL PHARMACEU forecast: see what analysts think of MADRIGAL PHARMACEU and suggest that you do with its stocks.